4-methyl-2,1,3-benzoxadiazole(CAS: 29091-40-5)

4-methyl-2,1,3-benzoxadiazole (CAS: 29091-40-5) is subject to various regulatory guidelines. Under the Globally Harmonized System (GHS), it is classified as a skin irritant and requires appropriate labeling. In Europe, it falls under REACH regulations, which require manufacturers and importers to register substances with the European Chemicals Agency. For FDA and EPA compliance, specific handling and storage instructions are recommended to ensure environmental safety and worker protection.

There are several alternatives to 4-methyl-2,1,3-benzoxadiazole (CAS: 29091-40-5) in organic synthesis. Common analogs include 2,1,3-benzothiadiazole and 2,1,3-benzoxazole. Isomers such as 2-methyl-1,3-benzoxadiazole can also be utilized. Alternative reagents like thiadiazoles or other heterocycles can serve as functional equivalents depending on the specific reaction conditions and desired properties.

The market for 4-methyl-2,1,3-benzoxadiazole (CAS: 29091-40-5) is driven by its applications in pharmaceuticals, agrochemicals, and materials science. Recent research trends focus on its use as a precursor for drug synthesis and as a component in antifungal and antibacterial formulations. Market trends indicate a steady demand, with ongoing exploration of its potential in sustainable chemical processes and advanced materials development.

Waste containing 4-methyl-2,1,3-benzoxadiazole (CAS: 29091-40-5) should be handled according to environmental protection regulations. Collect waste liquids in appropriate containers and ensure proper labeling. For solid waste, use airtight containers. Incineration or professional waste disposal services may be necessary. Always follow local waste management guidelines and ensure compliance with safety protocols to prevent environmental contamination and ensure worker safety.